TORONTO, ONTARIO / ACCESSWIRE / CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company") a global medical provider of electrocardiogram ("ECG") acquisition and management ...
The FDA has granted 510(k) clearance to Biofourmis’ RhythmAnalytics, a cloud-based software product that uses deep learning to read and interpret cardiac arrhythmias. According to a statement from the ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation of its software, which ...
SANTA CLARA, Calif. – HeartBeam, Inc. (NASDAQ: BEAT), a pioneer in cardiac care technology with a market capitalization of $65.76 million, has announced positive results from its VALID-ECG pivotal ...
Reorganizes To Accelerate Global Commercialization Strategy. HeartBeam (NASDAQ: BEAT) announced a strategic reorganization aimed at accelerating execution, expanding global market reach and improving ...
Tempus AI, Inc. (NASDAQ:TEM) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On. On June 11, 2026, Tempus AI, Inc. (NASDAQ:TEM) announced that a multi-center validation of ...
Apple’s latest smartwatch can now detect signs of a deadly heart condition – potentially saving lives across the UK. But Dr Helen Tyrer, a senior clinical research fellow at Imperial College London, ...
When Apple introduced the fourth iteration of its smartwatch, the big new selling point wasn’t a feature we typically associate with a watch or any sort of smart device. Instead, the company added a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results